C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/80 (2006.01) A61K 31/44 (2006.01) A61K 31/443 (2006.01) A61K 31/4436 (2006.01) A61K 31/4439 (2006.01) A61K 31/496 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) C07D 401/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 409/14 (2006.01) C07D 413/12 (2006.01) C07D 413/14 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2451249
The invention related to novel compounds of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, useful in the treatment of a (A chemical formula should be inserted here - please see paper copy enclosed) Formula (I) disease or condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to methods for preparing compounds of Formula (I) and their use as medicaments in the treatment of diseases mediated by glucokinase.
L'invention concerne de nouveaux composés représentés par la formule (I) ou un de leurs sels, solvates ou promédicaments, dans laquelle R?1¿, R?2¿, R?3¿, n et m possèdent les caractéristiques indiquées dans le descriptif. Ces composés sont utiles pour traiter une maladie ou un état, tel que le diabète de type 2, dans lesquels glucokinase (GLK) joue le rôle de médiateur. Elle concerne également des procédés servant à préparer des composés représentés par la formule (I), ainsi que leur utilisation sous forme de médicaments pour traiter des maladies dans lesquelles glucokinase joue un rôle intermédiaire.
Allen Joanne Victoria
Caulkett Peter William Rodney
Currie Gordon Stuart
Gaskin Harold
Hargreaves Rodney Brian
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Amino nicotinate derivatives as glucokinase (glk) modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino nicotinate derivatives as glucokinase (glk) modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino nicotinate derivatives as glucokinase (glk) modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2015545